Suppr超能文献

重症新型冠状病毒肺炎患者多器官功能损害分析

Analysis of multiple organ function damage in patients with severe COVID-19 pneumonia.

作者信息

Feng Shiyan, Wang Fengxin, Wu Weibo, Li Yinfeng, Chen Chuming, Li Jianming, Cao Mengli, Peng Ling, Zhang Peiyan, Wang Fuxiang

机构信息

Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen Third People's Hospital, Shenzhen, Guangdong Province, China.

出版信息

J Med Biochem. 2023 Aug 25;42(3):444-453. doi: 10.5937/jomb0-41502.

Abstract

BACKGROUND

This study aims to analyze the changes and significance of organ function indices in patients with severe Coronavirus Disease 2019 (COVID-19) pneumonia for prediction of major organ damages and guiding treatment schemes.

METHODS

63 patients with severe COVID-19 pneumonia were selected as the severe group and 73 patients with mild syndromes were selected as the mild group. SAS9.4 software was used for statistical analysis of the data.

RESULTS

Levels of ALT, AST, cTnI, Cr, PT, APTT and Ddimer of the severe group were significantly higher while PLT was lower than those of the mild group. The data of all quantitative variables were converted into categorical variables. Significantly higher levels of AST, ALB, D-dimer and higher proportion of bilateral lung involvement were observed from the severe group comparing to those in the mild group, while the difference in the other indices between the two groups was insignificant in statistical perspective.

CONCLUSIONS

There are significant differences in the levels of multiple organ function indices between the severe group and the mild group of patients with COVID-19 pneumonia infection. Through examining the relevant indices, conditions of patients' multiple organ function damage could be predicted and used as guidance of treatment.

摘要

背景

本研究旨在分析新型冠状病毒肺炎(COVID-19)重症患者器官功能指标的变化及其意义,以预测主要器官损伤并指导治疗方案。

方法

选取63例COVID-19重症肺炎患者作为重症组,73例轻症患者作为轻症组。采用SAS9.4软件对数据进行统计分析。

结果

重症组谷丙转氨酶(ALT)、谷草转氨酶(AST)、肌钙蛋白I(cTnI)、肌酐(Cr)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)及D-二聚体水平显著高于轻症组,而血小板(PLT)水平低于轻症组。将所有定量变量数据转换为分类变量。与轻症组相比,重症组AST、白蛋白(ALB)、D-二聚体水平显著升高,双侧肺受累比例更高,而两组间其他指标差异无统计学意义。

结论

COVID-19肺炎感染重症组与轻症组患者多项器官功能指标水平存在显著差异。通过检测相关指标,可预测患者多器官功能损伤情况并指导治疗。

相似文献

1
Analysis of multiple organ function damage in patients with severe COVID-19 pneumonia.
J Med Biochem. 2023 Aug 25;42(3):444-453. doi: 10.5937/jomb0-41502.
2
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
3
Evaluation of organ function in patients with severe COVID-19 infections.
Med Clin (Barc). 2020 Sep 11;155(5):191-196. doi: 10.1016/j.medcli.2020.05.012. Epub 2020 Jun 4.
4
Evaluation of organ function in patients with severe COVID-19 infections.
Med Clin (Engl Ed). 2020 Sep 11;155(5):191-196. doi: 10.1016/j.medcle.2020.05.015. Epub 2020 Sep 19.
5
[Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 May;32(5):559-563. doi: 10.3760/cma.j.cn121430-20200414-00518.
6
[Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].
Zhonghua Gan Zang Bing Za Zhi. 2020 Feb 20;28(2):107-111. doi: 10.3760/cma.j.issn.1007-3418.2020.02.003.
8
[Comparative analysis of clinical features between severe coronavirus disease 2019 and severe community acquired pneumonia].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 May;34(5):485-491. doi: 10.3760/cma.j.cn121430-20211013-01477.
9
[Clinical characteristics of liver damage in 30 patients with severe coronavirus disease 2019 in Sichuan area].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Aug;32(8):928-932. doi: 10.3760/cma.j.cn121430-20200513-00656.
10
Epidemiological and clinical characteristics of COVID-19 patients in Hengyang, Hunan Province, China.
World J Clin Cases. 2020 Jun 26;8(12):2554-2565. doi: 10.12998/wjcc.v8.i12.2554.

引用本文的文献

本文引用的文献

3
Overview of the pathogenesis of COVID-19 (Review).
Exp Ther Med. 2021 Sep;22(3):1011. doi: 10.3892/etm.2021.10444. Epub 2021 Jul 15.
4
Mechanisms of Hypoxia in COVID-19 Patients: A Pathophysiologic Reflection.
Indian J Crit Care Med. 2020 Oct;24(10):967-970. doi: 10.5005/jp-journals-10071-23547.
6
8
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.
J Clin Transl Hepatol. 2020 Mar 28;8(1):18-24. doi: 10.14218/JCTH.2020.00018. Epub 2020 Mar 30.
9
Kidney involvement in COVID-19 and rationale for extracorporeal therapies.
Nat Rev Nephrol. 2020 Jun;16(6):308-310. doi: 10.1038/s41581-020-0284-7.
10
COVID-19 in kidney transplant recipients.
Am J Transplant. 2020 Jul;20(7):1941-1943. doi: 10.1111/ajt.15891. Epub 2020 Apr 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验